What's happened
The government has announced a one-off programme that will provide two doses of the MenB vaccine to teenagers in Year 13 and under-25s starting university, amid outbreaks in Kent and other clusters. The initiative begins in July, aiming to cover about a million young people and reduce the risk of serious meningitis B illness this autumn.
What's behind the headline?
Key questions answered
- What changed? A one-off MenB vaccination programme has been activated ahead of the academic year.
- Who is affected? Teenagers in Year 13 and under-25 students entering university or certain FE settings.
Why it matters
- The Kent outbreak highlighted a shift in MenB risk factors, and officials say two doses will help mitigate larger outbreaks as students share accommodation.
What to watch
- JCVI guidance on whether a broader, permanent programme is advisable will shape future policy.
Reader takeaway
- Eligible students should follow NHS notifications and book doses in July/August to head off the autumn peak.
How we got here
Outbreaks of meningitis B in Kent and other clusters earlier this year prompted the emergency response. The vaccination programme targets those born between 1 Sept 2007 and 31 Aug 2008 and under-25 year-olds starting higher education, with doses given at least 28 days apart.
Our analysis
The Guardian (Nicola Davis) and The Independent (Jane Kirby) report on the government’s MenB vaccination plan, including quotes from health secretary James Murray and UKHSA officials.
Go deeper
- Should I expect this to become a routine vaccine for all young people?
- How will universities coordinate second-dose appointments in August?
- What does this mean for private MenB vaccination costs?